"Naïve" ProStrakan brought discredit to industry
This article was originally published in Scrip
Executive Summary
ProStrakan brought the pharmaceutical industry into disrepute as it scrambled to fix promotional material for Abstral (fentanyl citrate sublingual tablet), the UK's Prescription Medicines Code of Practice Authority has ruled.